CLINICAL RESEARCH: METABOLIC SYNDROME
Metabolic Syndrome and Age-Related Progression of Aortic Stiffness
Michel E. Safar, MD*,*,
Frédérique Thomas, MD ,
Jacques Blacher, MD*,
Rosine Nzietchueng, MD ,
Jeanne-Marie Bureau, MD ,
Bruno Pannier, MD and
Athanase Benetos, MD,
* Diagnosis Center, Hôtel-Dieu Hospital, Paris, France
Georges Pompidou European Hospital, Paris, France
IPC Center, Paris, France
Geriatric Center, Brabois Hospital, Nancy, France
Manuscript received May 9, 2005;
revised manuscript received July 20, 2005,
accepted August 1, 2005.
* Reprint requests and correspondence: Dr. Michel Safar, Diagnosis Center, Hôpital Hôtel-Dieu, 1, place du Parvis Notre-Dame, 75181 Paris Cedex 04, France. (Email: michel.safar{at}htd.ap-hop-paris.fr).
OBJECTIVES: The purpose of the study was to evaluate whether a clustering of metabolic risk factors might accelerate the progression of arterial stiffness with age in subjects with metabolic syndrome (MS).
BACKGROUND: Arterial stiffness is increased in MS, but the genetic and environmental factors that might influence its progression are unknown.
METHODS: Four hundred seventy-six subjects were classified at baseline according to their number of cardiovascular (CV) risk factors (from zero to three and more), after adjustment for smoking habits. The CV risk factors were: hypertension, body mass index, dyslipidemia, hypertriglyceridemia, and hyperglycemia, classified according to traditional criterions. Subjects were followed for six years and had, at the beginning and end of the survey, determinations of blood pressure (BP), heart rate (HR), and aortic pulse wave velocity (PWV).
RESULTS: At baseline, BP, HR, plasma creatinine, and PWV were significantly higher (p < 0.001) in the group with three and more CV risk factors than in groups with zero to two risk factors. During the follow-up, the increase in PWV, but not in pulse pressure, was significantly higher (p < 0.01) in the group with three and more risk factors (i.e., metabolic syndrome) than in other groups. Results were unmodified after adjustments for age, gender, baseline values, drug treatment, smoking habits, and mean arterial pressure.
CONCLUSIONS: Metabolic syndrome is associated with an increased progression of aortic stiffness with age, supporting premature senescence in these patients.
|
Abbreviations and Acronyms
| | BMI = body mass index | | CV = cardiovascular | | DBP = diastolic blood pressure |  = change from V1 to V2 | | MAP = mean arterial pressure | | MS = metabolic syndrome | | PP = pulse pressure | | PWV = pulse wave velocity | | SBP = systolic blood pressure | | V = visit |
|
This article has been cited by other articles:
|
|
|
|
 
J. M. SABIO, J. VARGAS-HITOS, M. ZAMORA-PASADAS, J. D. MEDIAVILLA, N. NAVARRETE, A. RAMIREZ, C. HIDALGO-TENORIO, L. JAIMEZ, J. MARTIN, J. JIMENEZ-ALONSO, et al.
Metabolic Syndrome Is Associated with Increased Arterial Stiffness and Biomarkers of Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus
J Rheumatol,
October 1, 2009;
36(10):
2204 - 2211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Holewijn, M. den Heijer, D. W. Swinkels, A. F. H. Stalenhoef, and J. de Graaf
The Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis
J. Clin. Endocrinol. Metab.,
August 1, 2009;
94(8):
2893 - 2899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Chirinos, S. S. Franklin, R. R. Townsend, and L. Raij
Body Mass Index and Hypertension Hemodynamic Subtypes in the Adult US Population
Arch Intern Med,
March 23, 2009;
169(6):
580 - 586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Giannattasio, P. Salvi, F. Valbusa, A. Kearney-Schwartz, A. Capra, M. Amigoni, M. Failla, L. Boffi, F. Madotto, A. Benetos, et al.
Simultaneous Measurement of Beat-to-Beat Carotid Diameter and Pressure Changes to Assess Arterial Mechanical Properties
Hypertension,
November 1, 2008;
52(5):
896 - 902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Roes, R. Alizadeh Dehnavi, J. J.M. Westenberg, H. J. Lamb, B. J.A. Mertens, J. T. Tamsma, and A. de Roos
Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function
Diabetes Care,
July 1, 2008;
31(7):
1442 - 1444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ghiadoni, G. Penno, C. Giannarelli, Y. Plantinga, M. Bernardini, L. Pucci, R. Miccoli, S. Taddei, A. Salvetti, and S. Del Prato
Metabolic Syndrome and Vascular Alterations in Normotensive Subjects at Risk of Diabetes Mellitus
Hypertension,
February 1, 2008;
51(2):
440 - 445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Safar
Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension
Hypertension,
July 1, 2007;
50(1):
167 - 171.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Serne, R. T. de Jongh, E. C. Eringa, R. G. IJzerman, and C. D.A. Stehouwer
Microvascular Dysfunction: A Potential Pathophysiological Role in the Metabolic Syndrome
Hypertension,
July 1, 2007;
50(1):
204 - 211.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Noma, C. Goto, K. Nishioka, D. Jitsuiki, T. Umemura, K. Ueda, M. Kimura, K. Nakagawa, T. Oshima, K. Chayama, et al.
Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic Stiffness
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
698 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
